Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
4Vets4Life is a Polish biotechnology company specializing in regenerative medicine for veterinary applications. The company focuses on the development and application of mesenchymal stem cell (MSC) therapies to treat various conditions in dogs, cats, and horses, including orthopedic injuries and chronic inflammatory diseases. Their core business involves providing specialized laboratory services for the isolation and expansion of stem cells for clinical use by veterinary practitioners. By utilizing advanced cell culture techniques, 4Vets4Life offers innovative biological treatments aimed at improving recovery times and quality of life for animals. The company collaborates closely with academic institutions to ensure their protocols are based on the latest scientific research. Currently, their products are commercially available to veterinary clinics across Poland and parts of Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 4VETS4LIFE.